Cardiff Lexington Corp. (CDIX) intrinsic value & 10-year financials

Cardiff Lexington Corp. (CDIX) has a Graham intrinsic value of $8.79 per share. At $0.06 on Oct 17, 2026, the stock trades 99% below that value. Over the last 10 fiscal years revenue grew 26.5% a year to $11.5M, with an average return on invested capital of 349.3%.

Graham intrinsic value
$8.79
Share price (Oct 17, 2026)
$0.06
Price vs Graham value
99% below
Market cap
$534.6K
Revenue (FY2025)
$11.5M
Revenue growth (10-yr CAGR)
26.5%
ROIC (10-yr avg)
349.3%
Free cash flow (FY2025)
—

CDIX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $11.5M -$5.5M — — 9.5% 8.2%
FY2024 $8.3M -$3.3M — — -2.3% -50.2%
FY2023 $11.9M $3.0M — — 43.8% 749.5%
FY2022 $12.0M -$5.4M — -$1.2M 14.1% 918.3%
FY2021 $9.9M $666.3K -$0.00 -$853.5K 16.8% 243.5%
FY2020 $10.9M — — — — —
FY2018 $2.4M -$6.3M — -$2.1M -181.3% 162.1%
FY2017 $1.7M -$5.0M — -$673.3K -162.9% 206.3%
FY2016 $1.2M -$2.3M — -$216.8K -187.8% 227.2%
FY2015 $1.4M -$3.9M -$0.00 -$185.2K -281.4% 678.6%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Cardiff Lexington Corp is a consistent compounder, expanding top-line revenue at 26.5% annually over the past decade.

Cardiff Lexington Corp has historically struggled to out-earn its cost of capital, averaging just -1.1% ROIC.

Over the decade, Cardiff Lexington Corp shows that management has aggressively returned capital to shareholders by retiring 99.9% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Cardiff Lexington Corp is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $8.79 per share.

CDIX stock: frequently asked questions

What is the intrinsic value of Cardiff Lexington Corp. (CDIX) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, CDIX's intrinsic value is about $8.79 per share.

Is CDIX stock undervalued?

At $0.06 (close on Oct 17, 2026), CDIX trades 99% below its Graham value of $8.79. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Cardiff Lexington Corp. grown?

Revenue went from $1.4M in fiscal 2015 to $11.5M in fiscal 2025, a compound annual growth rate of 26.5%. Net income was -$5.5M in fiscal 2025.

What is CDIX's return on invested capital?

Average ROIC over the last 10 fiscal years was 349.3%, and average return on equity was -386.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CDIX data come from?

From Cardiff Lexington Corp.'s annual 10-K filings on SEC EDGAR, most recently filed May 13, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar offices & clinics of doctors of medicine stocks